In fact, NLRC5 has been shown to regulate the Wnt/β‐catenin signaling pathway to promote cell proliferation and migration in both clear cell renal carcinoma and hepatocellular carcinoma [34, 35]. Here, NLRC5 is linked to clear cell renal carcinoma.